Dr. K Chitkara Profile

Professional Qualifications

• MBBS (India) with Distinctions, 1995

• MRCP (UK), 2001

• MD (Leicester), 2008

• CCT (UK) Cardiology, 2010

Professional Memberships and Affiliations

• British Cardiovascular Interventional Society (BCIS)

• Society of Catheter and Interventions (SCAI)

• European Club of Interventional Cardiologists (EUCIC)

Research & Publications

Dr. Chitkara Research Lead for the department of cardiology at Derby Hospital. Dr. Chitkara continues to be actively involved in ground breaking clinical research and Principal Investigator for various randomised clinical trials involving stents, aortic stenosis, atrial fibrillation, angina and moderate coronary artery disease. Dr. Chitkara has recently published book on Coronary Complications during PCI-survival handbook. 

Books:  

1. Complications of PCI – Survival handbook  

2. Preclinical assessment of Eptifibatide eluting stents

Trials: 

Principal Investigator for multi-centre studies: RIPCORD, BRICCS-AS, EMMACE4, ULTIMASTER, EAST, REDUAL PCI.

Abstracts & Papers:

1. A diagonal no like other –Case presentation TCT 2016

2. Audit of Nonagenarians PCI Outcome – presented at TCT 2015

3. Successful removal of an entrapped and knotted JL 3.5 catheter during right transradial cardiac catheterization by snaring and unwinding the catheter via femoral access –challenging case presented at TCT 2015

4. Computerised Tomography Calcium Score in a "real-world" cohort of elderly patients with new onset chest pain-a single centre experience.  SCAI Scientific session – USA 2015

5. Routine Pressure Wire Assessment at Time of Diagnostic Angiography: Is it Ready for Prime Time?  The RIPCORD Study. Circ Cardiovasc Interv. 2014;7:139-141 Chitkara K*, Nick Curzen et.

6. DES: 2nd Generation vs. 1st generation. Chitkara K*, Gershlick A.H. J. Interventional Cardiology (Interventional Cardiology –August 2010).

7. Drug Eluting Stents in patients with ST Elevation MI. Chitkara K*, Gershlick A.H. European Cardiovascular Disease – Vol.1, (Issue II) November 2009.

8. Eptifibatide eluting stents as an anti proliferative and anti thrombotic agent: in- vitro evaluation. Chitkara K*, Hogrefe K, Gershlick A.H. J Invasive Cardiol. 2006 Sep; 18(9):417-22.

9. Drug Eluting Stents in coronary atheromatous disease. Chitkara K*, Hogrefe K, Gershlick. Hospital Pharmacy Europe- 48-51 October 2003.

10. Drug Eluting Stents: Promises and Pitfalls. Chitkara K*, Bhandari M, Gershlick A.H. Interventional Cardiology Monitor- volume 10, No.1 2003.

Course Organiser

Course Director & Faculty

1. National & International Coronary Complications meeting: I have key interest in prevention of coronary complications and every year I organise interactive case based discussion course for final year SpRs and new Consultants in collaboration with a panel of experts, as I believes that complication cases often form the basis for a good discussion and are a learning opportunity for better management and prevention of coronary complications. Venue: Royal Derby Hospital –Derby & Aga Khan Hospital – Nairobi

2. STEMI AFRICA – Nairobi, I have been actively contributing in establishing heart attack services amongst various populations in Africa.

3. PCS

4. Heart Live conference  – Manchester Royal Infirmary 2015/2016/2017